Active substance
Trimipramine
- US FDA 6
- Health Canada 5
- NHS prices 3
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TRIMIPRAMINE MALEATE | EQ 25MG BASE; EQ 50MG BASE; EQ 100MG BASE | capsule · oral | ELITE LABS INC | Prescription | 2 Aug 2006 |
| TRIMIPRAMINE MALEATE | EQ 25MG BASE; EQ 50MG BASE; EQ 100MG BASE | capsule · oral | BRECKENRIDGE | Prescription | 15 Apr 2016 |
| SURMONTIL | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule · oral | TEVA WOMENS | Discontinued | 12 Jun 1979 |
| TRIMIPRAMINE MALEATE | EQ 25MG BASE | capsule · oral | USL PHARMA | Discontinued | |
| TRIMIPRAMINE MALEATE | EQ 50MG BASE | capsule · oral | USL PHARMA | Discontinued | |
| TRIMIPRAMINE MALEATE | EQ 100MG BASE | capsule · oral | USL PHARMA | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| TRIMIPRAMINE | 00740799 | 12.5 MG | TABLET · ORAL | AA PHARMA INC |
| TRIMIPRAMINE | 00740802 | 25 MG | TABLET · ORAL | AA PHARMA INC |
| TRIMIPRAMINE | 00740810 | 50 MG | TABLET · ORAL | AA PHARMA INC |
| TRIMIPRAMINE | 00740829 | 100 MG | TABLET · ORAL | AA PHARMA INC |
| TRIMIPRAMINE | 02070987 | 75 MG | CAPSULE · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Trimipramine 10mg tablets | £197.18 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Trimipramine 25mg tablets | £205.44 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Trimipramine 50mg capsules | £5.20 | 28 capsule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.